IRIS
POMPILIO, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.812
EU - Europa 3.015
AS - Asia 1.779
SA - Sud America 103
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 8.728
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.779
IT - Italia 683
SG - Singapore 679
CN - Cina 586
IE - Irlanda 528
UA - Ucraina 386
SE - Svezia 383
GB - Regno Unito 375
TR - Turchia 279
FR - Francia 184
DE - Germania 166
IN - India 104
BR - Brasile 92
RU - Federazione Russa 92
FI - Finlandia 82
VN - Vietnam 42
AT - Austria 33
HK - Hong Kong 29
NL - Olanda 18
BE - Belgio 17
JP - Giappone 17
ES - Italia 16
MX - Messico 16
CA - Canada 13
CH - Svizzera 13
CZ - Repubblica Ceca 12
EU - Europa 7
KR - Corea 7
IR - Iran 6
IQ - Iraq 4
PL - Polonia 4
RS - Serbia 4
TH - Thailandia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
BD - Bangladesh 3
DK - Danimarca 3
GR - Grecia 3
LB - Libano 3
PY - Paraguay 3
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
IL - Israele 2
NZ - Nuova Zelanda 2
PA - Panama 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
BZ - Belize 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
RO - Romania 1
SC - Seychelles 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 8.728
Salva come PNG Salva come JPEG
Città #
Chandler 835
Jacksonville 550
Dublin 523
Singapore 437
Dearborn 281
Princeton 252
Southend 208
Ashburn 184
Chieti 162
Nanjing 148
Izmir 142
Beijing 121
Wilmington 95
The Dalles 90
Santa Clara 86
Ann Arbor 79
Cambridge 74
Altamura 68
Pescara 55
Nanchang 48
Boardman 46
Los Angeles 46
Dong Ket 42
Washington 38
Vienna 29
Hong Kong 28
New York 27
Kunming 26
Rome 26
Hebei 25
Shenyang 24
Munich 23
Jiaxing 22
Norwalk 22
Woodbridge 21
Tianjin 20
Milan 19
Nuremberg 18
Brussels 16
Ancona 15
Teramo 15
Pune 13
Falls Church 12
Moscow 12
São Paulo 12
Shanghai 11
Changsha 10
Civitanova Marche 10
Houston 10
Kocaeli 10
Palermo 10
Amsterdam 9
Hefei 9
Helsinki 9
Varallo 9
Chicago 8
Guangzhou 8
Seattle 8
Ferrara 7
Grevenbroich 7
Jinan 7
Orange 7
Vittuone 7
Zhengzhou 7
Augusta 6
Brno 6
Ciudad de Villa de Álvarez 6
Geneva 6
Lanzhou 6
Melfi 6
Napoli 6
Putignano 6
Tokyo 6
Ascoli Piceno 5
Bellaterra 5
Castel Gandolfo 5
Chongqing 5
Hangzhou 5
L'aquila 5
Lappeenranta 5
Monfalcone 5
Paris 5
San Mateo 5
Udine 5
Zurich 5
Bologna 4
Chengdu 4
Chennevières-sur-marne 4
Coimbatore 4
Council Bluffs 4
Iesi 4
Messina 4
Montreal 4
New Delhi 4
Rio de Janeiro 4
Sabadell 4
Tappahannock 4
Tehran 4
Bari 3
Belgrade 3
Totale 5.370
Salva come PNG Salva come JPEG
Nome #
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 195
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 138
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 125
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. 112
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 108
Colonic adenoma-associated Escherichia coli express specific phenotypes 107
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 106
Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA). 106
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 103
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 98
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 98
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 98
In vitro microbiology studies on a new peritoneal dialysis connector 95
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 94
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 93
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 91
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 90
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 89
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 89
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 88
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 87
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 87
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 86
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 85
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 85
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 84
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 83
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 83
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 83
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 83
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 83
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 82
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 82
Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain. 81
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. 81
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 80
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 80
Isolation of colistin-resistant Hafnia alvei. 80
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 79
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 79
Normal breathing releases SARS-CoV-2 into the air 79
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 79
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 79
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 78
Eparina sodica stimola la formazione di biofilm da parte di Providencia stuartii. 77
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. 77
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 76
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection 76
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 76
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 75
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 75
Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. 74
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 74
Disomeostasi cationica in un modello murino di infezione polmonare da Stenotrophomonas maltophilia 74
A cystic fibrosis child with lung function decline 74
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 74
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 74
Multidrug-resistant Geotrichum capitatum from a haematology ward. 73
Haemophilus influenzae in children with cystic fibrosis: antimicrobial susceptibility, molecular epidemiology, distribution of adhesins and biofilm formation. 73
Determinazione di Ciprofloxacina e Levofloxacina in espettorato da pazienti affetti da fibrosis cistica mediante MEPS-HPLC-PDA 73
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 72
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 72
Olive Pâté by Multi-Phase Decanter as Potential Source of Bioactive Compounds of Both Nutraceutical and Anticancer Effects 72
Tuberculosis-like pneumonias by the aerobic actinomycetes Rhodococcus, Tsukamurella and Gordonia. 72
Factors associated with adherence to and biofilm formation on polystyrene byStenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. 71
Ruolo epidemiologico del biofilm in isolati di Stenotrophomonas maltophilia da pazienti con fibrosi cistica e da pazienti ricoverati in unità di terapia intensiva 71
New insights in Staphylococcus pseudintermedius pathogenicity: Antibiotic-resistant biofilm formation by a human wound-associated strain 70
V240H replacement, by site-directed mutagenesis, increases resistance toward carbapenems in TEM-149 ESBL producing E. coli. 69
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 69
Clonal diversity, biofilm formation, and antimicrobial resistance among Stenotrophomonas maltophilia strains from cystic fibrosis and non-cystic fibrosis patients 69
Hafnia alvei from the farm to the delivery room 69
Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. 68
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 68
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. 67
Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients 66
Attvità antibatterica ed anti-biofilm del peptide P19(9/B) verso isolati multi-resistenti isolati da pazienti affetti da fibrosi cistica 65
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 65
Identification of CTX-M-15 and CTX-M-27 in Antibiotic-Resistant Gram-Negative Bacteria Isolated from Three Rivers Running in Central Italy 65
Toward optimization of antimicrobial peptides for the treatment of multidrug resistant infections in cystic fibrosis. 65
Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. 64
Corynebacterium glucuronolyticum causing genitourinary tract infection: Case report and review of the literature 64
Patogenesi in fibrosi cistica: clearance di Stenotrophomonas maltophilia ed infiammazione in un modello murino di infezione polmonare. 63
Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. 63
Ambient air pollution and respiratory bacterial infections, a troubling association: epidemiology, underlying mechanisms, and future challenges 63
Bacterial contamination of platelets and septic transfusions: review of the literature and discussion on recent patents about biofilm treatment. 62
An ultrathin film membrane based on a nano-channeled reduced graphene oxide with enhanced antibacterial properties 61
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 61
Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms? 61
ONE-STEP DEPOSITION METHOD FOR THE SYNTHESIS OF A NANOCOMPOSITE MEMBRANE BASED ON REDUCED GRAPHENE OXIDE/ZEOLITE-A FOR ADSORPTION OF METAL IONS WITH ENHANCED ANTIBACTERIAL PROPERTIES 60
Modulation of biofilm formation by Stenotrophomonas maltophilia during chronic lung infection in cystic fibrosis patients: a longitudinal population study 60
Molecular genotyping, adhesion and biofilm formation in methicillin-resistant Staphylococcus aureus clinical strains. 59
Formazione di biofilm, diversità genetica e virulenza in Stenotrophomonas maltophilia isolati da pazienti con fibrosi cistica. 59
Stenotrophomonas maltophilia phenotypic and genotypic diversity during a 10-year infection in the lungs of a cystic fibrosis patient 59
In vitro activity of multi-branched peptides against planktonic and biofilm cells of Pseudomonas aeruginosa from cystic fibrosis patients. 59
Antidiabetic “gliptins” affect biofilm formation by Streptococcus mutans 58
Biofilm formation and antibiotic resistance in Stenotrophomonas maltophilia: a prospective multicentre study 58
The anti-microbial peptide (Lin-SB056-1)2-K reduces pro-inflammatory cytokine release through interaction with Pseudomonas aeruginosa lipopolysaccharide 58
Attvità antibatterica ed anti-biofilm di BMAP-27 e BMAP-28 verso ceppi multi-resistenti isolati da pazienti affetti da fibrosi cistica 57
“Indirect pathogenicity” in cystic fibrosis during pulmonary exacerbations: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in a Galleria mellonella model. 56
Ruolo della componente flagellare nella patogenicità di Stenotrophomonas maltophilia in fibrosi cistica. 55
Totale 7.851
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020204 0 0 0 0 0 0 0 0 0 0 184 20
2020/2021751 105 18 150 25 56 135 13 18 40 98 24 69
2021/2022828 27 39 31 121 60 22 35 62 85 20 94 232
2022/20232.073 179 270 156 248 184 384 105 152 254 25 83 33
2023/2024918 61 50 79 33 80 250 194 47 12 25 8 79
2024/20251.665 119 360 245 73 54 109 108 102 283 103 109 0
Totale 9.381